Entia Liberty: Home Study - Evaluation of Patient Preference for a Novel Full Blood Count Home Testing Device Versus Routine Venous Monitoring
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Entia Ltd
- 入组人数
- 22
- 试验地点
- 1
- 主要终点
- To assess patient preference for the Liberty self-testing pathway as compared to standard of care.
研究概览
简要总结
Participants will be testing with the home monitoring device over the course of their treatment. They are to self-test on days where they are due to be going into hospital for their routine pre-treatment blood tests. Participants will be asked to fill in interim questionnaires and a final questionnaire to answer the study objectives.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adequate English language skills (not requiring a translator) to participate in participant training and use the Liberty device
- •Patients willing and able to perform capillary blood self-testing at the same frequency as routine full blood count monitoring
- •Patients capable of providing informed consent before attending training
- •Patients able to attend a 1-hour virtual training session within 2 weeks of joining the study
- •Patients with a home Wi-Fi network or with adequate coverage at home via a 4G network
- •Patients with access to a laptop or smartphone to facilitate training
- •Patients with a diagnosis of ovarian or breast cancer
- •Patients whose HCPs can confirm are undergoing systemic anti-cancer treatments within two weeks of enrolment, with treatment expected to continue for at least two cycles
排除标准
- •Patients with haematological malignancies
- •Patients with eyesight or hearing limitations or other disabilities that preclude the use of the Liberty device or participation in training unless they have a nominated caregiver who is capable of assisting with each test
结局指标
主要结局
To assess patient preference for the Liberty self-testing pathway as compared to standard of care.
时间窗: 12 months
Patients will undergo the study procedures without change to their current pathway, at the end of the study, patients will compare the interventions via a SURVEY. The investigators will measure the success of the comparison by the % of patients who have chosen the investigators' product over the standard of care (4-5 rating out of 5).
次要结局
未报告次要终点